SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026
Rhea-AI Summary
SI-BONE (Nasdaq: SIBN) announced its participation in the 2026 Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY. Management will host a fireside chat on Monday, September 14, 2026, at 8:30 a.m. PT / 11:30 a.m. ET. A live audio webcast will be available in the Investors section of the company’s website, with replay access for at least 90 days.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 03 | 2Q26 earnings report | Positive | -0.1% | Raised 2026 guidance despite improved losses and positive adjusted EBITDA |
| Jul 20 | 2Q26 earnings scheduling | Neutral | -0.5% | Announced second-quarter results date and conference-call timing |
| Jun 04 | Conference presentation | Neutral | +1.6% | Scheduled fireside chat at the Truist Securities MedTech Conference |
| May 11 | 1Q26 earnings report | Positive | +19.7% | Raised revenue guidance and reported improved adjusted EBITDA |
| Apr 30 | Conference presentation | Neutral | +6.6% | Scheduled fireside chat at the BofA Healthcare Conference |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical earnings reactions were mixed, while prior conference-presentation announcements were followed by positive 24-hour moves.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA CLARA, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Monday, September 14, 2026, at 8:30 a.m. Pacific Time/ 11:30 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: SI-BONE, Inc. - 1774169. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone. With expertise in biomechanical design and anatomy specific innovation, SI-BONE has built a technology platform with market-leading applications centered on the spinopelvic anatomy. SI-BONE continues to leverage the deep experience in addressing the challenges of low-density bone in the sacrum to develop unique technologies that are targeting new clinical adjacencies to help improve outcomes for patients with compromised bone. Since 2009, SI-BONE has supported physicians in performing a total of over 150,000 procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including four randomized controlled trials and over 190 peer reviewed publications.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved.
Investor Contact
Saqib Iqbal
VP, FP&A, and Investor Relations
investors@SI-BONE.com
